Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

2-Methyl-iPALT

Add links
From Wikipedia, the free encyclopedia
(Redirected from 2-methyl-iPALT)

2-Methyl-iPALT
Clinical data
Other names2-Me-iPALT; 2-Methyl-ALiPT; 2-Me-ALiPT; ASR-3002; ASR3002; 2-Methyl-N-isopropyl-N-allyltryptamine; 2-Methyl-N-allyl-N-isopropyltryptamine
Drug classSerotonin receptor modulator; Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • N-[2-(2-methyl-1H-indol-3-yl)ethyl]-N-prop-2-enylpropan-2-amine
CAS Number
PubChem CID
Chemical and physical data
FormulaC17H24N2
Molar mass256.393 g·mol−1
3D model (JSmol)
  • CC1=C(C2=CC=CC=C2N1)CCN(CC=C)C(C)C
  • InChI=1S/C17H24N2/c1-5-11-19(13(2)3)12-10-15-14(4)18-17-9-7-6-8-16(15)17/h5-9,13,18H,1,10-12H2,2-4H3
  • Key:QXAIQMVRYZDEJS-UHFFFAOYSA-N

2-Methyl-iPALT, or 2-methyl-ALiPT, also known as 2-methyl-N-isopropyl-N-allyltryptamine or by its developmental code name ASR-3002, is a serotonin receptor modulator of the tryptamine family.[1] It is the 2-methyl derivative of iPALT.[1] The drug is very similar in structure to 2-methyl-DiPT, which Alexander Shulgin hypothesized would be a DiPT-like selective auditory hallucinogen but never synthesized nor tested.[1]

Pharmacology

[edit]

Pharmacodynamics

[edit]

2-Methyl-iPALT is a non-selective serotonin receptor agonist, including of the serotonin 5-HT1B, 5-HT2A, 5-HT2B, and 5-HT6 receptors, but not of the serotonin 5-HT1A receptor.[1] However, it shows rather low, micromolar potency for most of these actions, with for example 264-fold lower potency as a serotonin 5-HT2A receptor agonist than the known psychedelic drug 5-MeO-iPALT (ASR-3001).[1] The drug is inactive as a monoamine reuptake inhibitor.[1]

Chemistry

[edit]

Synthesis

[edit]

The chemical synthesis of 2-methyl-iPALT has been described.[1]

Analogues

[edit]

Analogues of 2-methyl-iPALT include 5-MeO-iPALT (ASR-3001), 4-HO-iPALT, 2-methyl-DMT, 2-methyl-DET, and 2-methyl-DiPT, among others.[1][2]

History

[edit]

2-Methyl-iPALT was patented by the Alexander Shulgin Research Institute (ASRI) in 2024.[1]

See also

[edit]

References

[edit]
  1. 1 2 3 4 5 6 7 8 9 US 20240277665A1, Daley PF, Cozzi NV, Callaway WB, "Asymmetric allyl tryptamines", issued 4 March 2024, assigned to Alexander Shulgin Research Institute Inc.
  2. ↑ Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
Retrieved from "https://en.wikipedia.org/w/index.php?title=2-Methyl-iPALT&oldid=1360364393"